AI CAPITAL INTELLIGENCE
德睿智药 · Series B · USD 52,000,000 · 2026-07-08
Financing facts, at a glance
德睿智药: financing disclosed on 2026-07-08, Series B, USD 52,000,000. Named investors: Not disclosed. This is the amount disclosed for the financing, not a company valuation or an individual investor commitment.
Original source 1 · Original source 2 · Original source 3 · Original source 4 · Original source 5 · Original source 6 · Original source 7
德睿智药 is recorded in the Industry AI / Drug discovery & life sciences segment. The disclosed financing is Series B, with an amount of USD 52,000,000. Investor names were not disclosed in this record.
- Disclosed company name
- 德睿智药（MindRank）
- Disclosure date
- 2026-07-08
- Round
- Series B
- Financing amount
- USD 52,000,000
- Market coverage
- China
- Sector
- Industry AI / Drug discovery & life sciences
- Product form
- Enterprise software
Disclosed investors
Not disclosed
Original sources
- Source 1 · www.vbdata.cn
- Source 2 · www.mindrank.ai
- Source 3 · www.vcbeathealth.com
- Source 4 · www.mindrank.ai
- Source 5 · eu.36kr.com
- Source 6 · www.mindrank.ai
- Source 7 · c.m.163.com
Record reviewed as of . Reported ranges and lower bounds are retained. Financing proceeds are not company valuation.